BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions
Authors:
Spyridon Bakas,
Siddhesh P. Thakur,
Shahriar Faghani,
Mana Moassefi,
Ujjwal Baid,
Verena Chung,
Sarthak Pati,
Shubham Innani,
Bhakti Baheti,
Jake Albrecht,
Alexandros Karargyris,
Hasan Kassem,
MacLean P. Nasrallah,
Jared T. Ahrendsen,
Valeria Barresi,
Maria A. Gubbiotti,
Giselle Y. López,
Calixto-Hope G. Lucas,
Michael L. Miller,
Lee A. D. Cooper,
Jason T. Huse,
William R. Bell
Abstract:
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and as…
▽ More
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and assessing their heterogeneity is crucial for choosing the precise treatment and potentially enhancing patient survival rates. In the gold-standard histopathology-based approach to tumor diagnosis, detecting various morpho-pathological features of distinct histology throughout digitized tissue sections is crucial. Such "features" include the presence of cellular tumor, geographic necrosis, pseudopalisading necrosis, areas abundant in microvascular proliferation, infiltration into the cortex, wide extension in subcortical white matter, leptomeningeal infiltration, regions dense with macrophages, and the presence of perivascular or scattered lymphocytes. With these features in mind and building upon the main aim of the BraTS Cluster of Challenges https://www.synapse.org/brats2024, the goal of the BraTS-Path challenge is to provide a systematically prepared comprehensive dataset and a benchmarking environment to develop and fairly compare deep-learning models capable of identifying tumor sub-regions of distinct histologic profile. These models aim to further our understanding of the disease and assist in the diagnosis and grading of conditions in a consistent manner.
△ Less
Submitted 17 May, 2024;
originally announced May 2024.
